Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6524 |
filingDate |
2006-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c933fe208a23d2dd27295e1b2521f060 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95402f4e98f0c7eea13ebdd105bceb4c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f0d855ceaf191e2f3bed217e904fb0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02aa39d75e8daf6cd5abbb609048df1e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d4ccbbd56f8138de98454707724c165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35fc4b1f808a227d3c722faa253ee169 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aea5f1ee72578c290ca32215b8756e7d |
publicationDate |
2007-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
HK-1091211-A1 |
titleOfInvention |
Nucleotide analog compositions |
abstract |
The invention provides crystalline forms of adefovir dipivoxil and methods to prepare the crystals. The compositions and methods of the present invention have desirable properties for large scale synthesis of crystalline adefovir dipivoxil or for its formulation into therapeutic dosages. Invention compositions include an anhydrous crystal form of adefovir dipivoxil. |
priorityDate |
1997-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |